Home coronavirus Johnson & Johnson files for emergency use authorization from FDA for its...

Johnson & Johnson files for emergency use authorization from FDA for its single-dose COVID-19 vaccine

82,124FansLike
2,966FollowersFollow
2,690SubscribersSubscribe
82,124FansLike
3,122FollowersFollow
2,690SubscribersSubscribe

Updated: February 27, 2021

Johnson & Johnson on Thursday filed for an emergency use authorization of its single-dose COVID-19 vaccine from the U.S. Food and Drug Administration (FDA).

It is being described as a game changer in global efforts to finally bring the respiratory disease under control in the United States and around the world.

[read_more id="2" more="Read full article" less="Read less"]

Although not as effective as the mRNA vaccines from Pfizer-BioNtech and Moderna, the Johnson & Johnson’s vaccine has unique advantages: it is only a one-shot vaccine, easier to store and reportedly cheaper to produce. It is expected to reach more people.

“Upon authorization of our investigational COVID-19 vaccine for emergency use, we are ready to begin shipping,” Paul Stoffels, J&J’s chief scientific officer, said in a statement on Thursday. “We are working with great urgency to make our investigational vaccine available to the public as quickly as possible.”

Hundreds of millions of Americans still need access to vaccinations, and pharmaceutical manufacturing companies are in a race to deliver. Johnson & Johnson was one of the first funded by the United States government. Under the Trump administration, $456 million was invested in trials, resulting in a one-billion-dollar deal to provide 100 million shots. 

Johnson & Johnson is not the only company working on a vaccine, Pfizer/BioNTech, and Moderna are all planning to deliver around 200 million doses, working closely with the Biden administration. 

The major downside is the emergence of variant strains of COVID-19, and it’s believed that the Johnson & Johnson single-dose-shot will be less effective against a South Africa Covid-19 strain, falling to just 57 percent effectiveness. Variant strains, dubbed B.1.351, have been discovered in the U.S., bringing new challenges for pharmaceutical manufacturing companies still working on getting the first vaccine approved for the original strain of COVID-19. 

The Food and Drug Administration (FDA) is reviewing Johnson & Johnson’s vaccine and plans to publicly and transparently share their findings, but this will take weeks.

[/read_more]

Kristi Pelzel
Kristi Pelzel
Kristi Pelzel is a Senior International Correspondent at Today News Africa, working across U.S. and African markets, based in Washington, D.C. Her expertise spans broadcast, digital, and social media communication, nested with policy research, analysis, and writing. A member of the National Press Club in Washington, D.C., Kristi holds a B.A. from the Academy of Art University, San Francisco, California, and an M.A. from Georgetown University, Washington, D.C.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Now

TRENDING

Human Rights Watch concludes Abiy Ahmed’s soldiers bombed civilians to death, schools, hospitals and markets in Tigray region

Ethiopian federal forces carried out apparently indiscriminate shelling of urban areas in the Tigray region in November 2020 in violation of the laws of war, Human Rights Watch said on Wednesday. Artillery attacks at the start of the armed conflict struck homes, hospitals, schools, and markets in the city of Mekelle, and the towns of Humera and Shire, killing at least 83 civilians, including children, and wounding...

Stay connected

[/read_more]

[read_more id="2" more="Read full article" less="Read less"]

error: Alert: Content is protected !!
Reddit
Tweet
Share
Share
Pocket
Share
More